[Lymphomatoid granulomatosis].
Wakatsuki
S
S
Department of Surgical Pathology, Chiba Cancer Center Hospital.
Takagi
T
T
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D008230:Lymphomatoid Granulomatosis / Q000175:diagnosis / Q000628:therapy; D011239:Prednisolone / Q000627:therapeutic use; D011994:Recombinant Proteins
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D016572:Cyclosporine; D003520:Cyclophosphamide; D011239:Prednisolone